The Prognostic Utility of Normal Karyotype Fraction in Acute Myeloid Leukemia
Clinical Lymphoma Myeloma and Leukemia · 2026-10 · 26 (10) · e1160-e1174
DOI: 10.1016/j.clml.2026.08.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2026-10. Verfasst von Ameed Bawwab und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Cleveland Clinic, Cleveland, OH. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Karyotyping, Karyotype. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Cleveland Clinic, Cleveland, OH.
- Department of Quantitative Health Sciences, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.
- Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.
- Department of Pathology and Laboratory Medicine, Cleveland Clinic Diagnostics Institute, Cleveland, OH.
- Department of Cancer Sciences and Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH.
- Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute Blood and Marrow Transpla…
Zitieren
APA
Bawwab, A., Zabor, E. C., Khatib, L., Albliwi, M., Hanna, J., El-Asmar, J., Nurse, D. P., Abuamsha, H., Abu-Farsakh, Y., Rauf, A., Mohamed, A., Alchirazi, M. A., Nakitandwe, J., Bosler, D. S., Parthasarathy, P. B., Alban, T., Jain, A. G., Molina, J. C., Balderman, S., …, & Mustafa Ali, M. K. (2026). The Prognostic Utility of Normal Karyotype Fraction in Acute Myeloid Leukemia. Clinical Lymphoma Myeloma and Leukemia, 26(10), e1160-e1174. https://doi.org/10.1016/j.clml.2026.08.005
Vancouver
Bawwab A, Zabor EC, Khatib L, Albliwi M, Hanna J, El-Asmar J, et al. The Prognostic Utility of Normal Karyotype Fraction in Acute Myeloid Leukemia. Clinical Lymphoma Myeloma and Leukemia. 2026;26(10):e1160-e1174. doi:10.1016/j.clml.2026.08.005
BibTeX
@article{Bawwab2026,
author = {Bawwab, Ameed and Zabor, Emily C and Khatib, Lana and Albliwi, Moath and Hanna, John and El-Asmar, Jessica and Nurse, Daniel P and Abuamsha, Hasan and Abu-Farsakh, Yomna and Rauf, Asad and Mohamed, Ahmed and Alchirazi, Muaz Alsabbagh and Nakitandwe, Joy and Bosler, David S and Parthasarathy, Prerana Bangalore and Alban, Tyler and Jain, Akriti G and Molina, John C and Balderman, Sophia and Singh, Abhay and Gerds, Aaron T and Mukherjee, Sudipto and Sobecks, Ronald and Advani, Anjali S and Carraway, Hetty E and Astbury, Caroline and Mustafa Ali, Moaath K},
title = {The Prognostic Utility of Normal Karyotype Fraction in Acute Myeloid Leukemia},
journal = {Clinical Lymphoma Myeloma and Leukemia},
year = {2026},
volume = {26},
number = {10},
pages = {e1160--e1174},
doi = {10.1016/j.clml.2026.08.005}
}
EUVIMED